Dr. Hönle AG Statistics

Total Valuation

Dr. Hönle AG has a market cap or net worth of GBP 42.64 million. The enterprise value is 82.91 million.

Market Cap	42.64M
Enterprise Value	82.91M

Important Dates

The next estimated earnings date is Thursday, May 8, 2025.

Earnings Date	May 8, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	4.52M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.54
PB Ratio	0.65
P/TBV Ratio	0.78
P/FCF Ratio	36.42
P/OCF Ratio	14.36
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 16.78, with an EV/FCF ratio of 70.80.

EV / Earnings	-7.73
EV / Sales	1.01
EV / EBITDA	16.78
EV / EBIT	260.41
EV / FCF	70.80

Financial Position

The company has a current ratio of 1.89, with a Debt / Equity ratio of 0.68.

Current Ratio	1.89
Quick Ratio	0.73
Debt / Equity	0.68
Debt / EBITDA	9.48
Debt / FCF	38.30
Interest Coverage	0.15

Financial Efficiency

Return on equity (ROE) is -14.73% and return on invested capital (ROIC) is 0.14%.

Return on Equity (ROE)	-14.73%
Return on Assets (ROA)	0.12%
Return on Invested Capital (ROIC)	0.14%
Return on Capital Employed (ROCE)	0.26%
Revenue Per Employee	136,251
Profits Per Employee	-18,339
Employee Count	590
Asset Turnover	0.60
Inventory Turnover	1.09

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -59.00% in the last 52 weeks. The beta is 1.68, so Dr. Hönle AG's price volatility has been higher than the market average.

Beta (5Y)	1.68
52-Week Price Change	-59.00%
50-Day Moving Average	9.36
200-Day Moving Average	13.19
Relative Strength Index (RSI)	38.40
Average Volume (20 Days)	165

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Dr. Hönle AG had revenue of GBP 79.71 million and -10.73 million in losses. Loss per share was -1.77.

Revenue	79.71M
Gross Profit	49.39M
Operating Income	265,457
Pretax Income	-9.71M
Net Income	-10.73M
EBITDA	3.60M
EBIT	265,457
Loss Per Share	-1.77

Full Income Statement

Balance Sheet

The company has 6.18 million in cash and 44.85 million in debt, giving a net cash position of -38.67 million.

Cash & Cash Equivalents	6.18M
Total Debt	44.85M
Net Cash	-38.67M
Net Cash Per Share	n/a
Equity (Book Value)	65.49M
Book Value Per Share	10.76
Working Capital	22.71M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.97 million and capital expenditures -1.80 million, giving a free cash flow of 1.17 million.

Operating Cash Flow	2.97M
Capital Expenditures	-1.80M
Free Cash Flow	1.17M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 61.96%, with operating and profit margins of 0.33% and -13.46%.

Gross Margin	61.96%
Operating Margin	0.33%
Pretax Margin	-12.18%
Profit Margin	-13.46%
EBITDA Margin	4.52%
EBIT Margin	0.33%
FCF Margin	1.47%

Dividends & Yields

Dr. Hönle AG does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-25.16%
FCF Yield	2.75%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Dr. Hönle AG has an Altman Z-Score of 1.89. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.89
Piotroski F-Score	n/a